SpaceFOMO
SpaceFOMO
Back to Feed
56 FOMO · ADS Group

Collaboration to support in-orbit pharmaceuticals manufacturing

AI Executive Summary

The UK Space Agency awarded BioOrbit a £250,000 feasibility study under its Unlocking Space Portfolio to define the regulatory pathway for manufacturing pharmaceuticals in orbit. BioOrbit, the MHRA, and the UK Space Agency will assess whether existing terrestrial pharmaceutical regulations apply to in-orbit production for patient use.

Linked Moments

Get space signals in your inbox

A weekly digest of the moments you'd regret missing. Starting soon: get on the list.